News
-
-
-
COMMUNIQUÉ DE PRESSE
Monogram Technologies Upsizes 8.00% Series D Convertible Cumulative Preferred Stock and Warrant Offering to $12.5 Million
Monogram Technologies Inc. upsizes continuous offering to $12.5M for Series D Preferred Stock and common stock purchase warrants, enabling further innovation in orthopedic surgery -
-
-
COMMUNIQUÉ DE PRESSE
Monogram Technologies Reports Second Quarter 2024 Financial Results
Monogram Technologies Inc. reports successful FDA 510(k) Application and collaboration with Shalby Limited for mBôs TKA System. Company also hosts business update conference call and presents Q2 2024 financial and operational results -
-
-
COMMUNIQUÉ DE PRESSE
Monogram Technologies Secures Initial Strategic Clinical Trial Collaboration
Monogram Technologies Inc. announces clinical trial collaboration with Shalby Limited for mBÈs TKA System, following 510(k) submission and FDA approval. Shalby recognized as global leader in orthopedic surgeries -